Gossamer Bio Inc (GOSS)vsInsmed Inc (INSM)
GOSS
Gossamer Bio Inc
$0.38
+10.61%
HEALTHCARE · Cap: $99.14M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 1151% more annual revenue ($606.42M vs $48.47M). GOSS leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
GOSS
Hold39
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 47.1% year-over-year
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -7.8% — below average capital efficiency
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : GOSS
The strongest argument for GOSS centers on Revenue Growth. Revenue growth of 47.1% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : GOSS
The primary concerns for GOSS are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
GOSS profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
GOSS carries more volatility with a beta of 2.11 — expect wider price swings.
GOSS is growing revenue faster at 47.1% — sustainability is the question.
GOSS generates stronger free cash flow (-48M), providing more financial flexibility.
Bottom Line
GOSS scores higher overall (39/100 vs 39/100) and 47.1% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Gossamer Bio Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?